Congratulations to a great rheumatologist, Dr. Rita Jain, newly appointed Executive Vice President, Chief Medical Officer for ChemoCentryx, who's new C5a inhibitor avacopan (Tavneos) was just FDA approved for ANCA-assoc vasculitis! https://t.co/udhjSFF1Q0